Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Cloud

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 7, 2013
Tardive dyskinesia: therapeutic options for an increasingly common disorderLeslie J Cloud, Deepti Zutshi, Stewart A Factor
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|November 7, 2014
Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder ClinicDeepti Zutshi, Leslie J Cloud, Stewart A Factor
Biotechnology Progress|July 1, 1996
A quantitative immunoassay utilizing Escherichia coli cells possessing surface-expressed single chain Fv moleculesG Chen, J Cloud, G Georgiou, et al.
Breast Cancer Research and Treatment|January 22, 2015
The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family RegistryAnn J Cloud, Ashley Thai, Yuyan Liao, et al.
Expert Review of Neurotherapeutics|October 3, 2019
Therapeutic approaches to cholinergic deficiency in Lewy body diseasesMatthew J Barrett, Leslie J Cloud, Harsh Shah, et al.
Current Treatment Options in Neurology|March 3, 2011
Tardive dyskinesiaPratibha G Aia, Gonzalo J Revuelta, Leslie J Cloud, et al.
Developmental Biology|November 30, 2005
The C. elegans histone deacetylase HDA-1 is required for cell migration and axon pathfindingAnna Y Zinovyeva, Serena M Graham, Veronica J Cloud, et al.
American Journal of Epidemiology|January 9, 2015
Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reportersParisa Tehranifar, Hui-Chen Wu, Tom Shriver, et al.
Time|November 6, 2001
The victims. Facing the endJ Tyrangiel, M Orecklin, J Poniewozik, et al.
Plos One|December 16, 2017
Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family RegistryNur Zeinomar, Ashley Thai, Ann J Cloud, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|December 7, 2013
Tardive dyskinesia: therapeutic options for an increasingly common disorderLeslie J Cloud, Deepti Zutshi, Stewart A Factor
Tremor and Other Hyperkinetic Movements (New York, N.Y.)|November 7, 2014
Tardive Syndromes are Rarely Reversible after Discontinuing Dopamine Receptor Blocking Agents: Experience from a University-based Movement Disorder ClinicDeepti Zutshi, Leslie J Cloud, Stewart A Factor
Biotechnology Progress|July 1, 1996
A quantitative immunoassay utilizing Escherichia coli cells possessing surface-expressed single chain Fv moleculesG Chen, J Cloud, G Georgiou, et al.
Breast Cancer Research and Treatment|January 22, 2015
The impact of cancer prevention guideline adherence on overall mortality in a high-risk cohort of women from the New York site of the Breast Cancer Family RegistryAnn J Cloud, Ashley Thai, Yuyan Liao, et al.
Expert Review of Neurotherapeutics|October 3, 2019
Therapeutic approaches to cholinergic deficiency in Lewy body diseasesMatthew J Barrett, Leslie J Cloud, Harsh Shah, et al.
Current Treatment Options in Neurology|March 3, 2011
Tardive dyskinesiaPratibha G Aia, Gonzalo J Revuelta, Leslie J Cloud, et al.
Developmental Biology|November 30, 2005
The C. elegans histone deacetylase HDA-1 is required for cell migration and axon pathfindingAnna Y Zinovyeva, Serena M Graham, Veronica J Cloud, et al.
American Journal of Epidemiology|January 9, 2015
Validation of family cancer history data in high-risk families: the influence of cancer site, ethnicity, kinship degree, and multiple family reportersParisa Tehranifar, Hui-Chen Wu, Tom Shriver, et al.
Time|November 6, 2001
The victims. Facing the endJ Tyrangiel, M Orecklin, J Poniewozik, et al.
Plos One|December 16, 2017
Alcohol consumption and breast cancer-specific and all-cause mortality in women diagnosed with breast cancer at the New York site of the Breast Cancer Family RegistryNur Zeinomar, Ashley Thai, Ann J Cloud, et al.
Pageof 5